Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
Sequence NLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV Purification Affinity purification
The potential for weight loss is interesting, but I think the most interesting reason to pursue glucagon agonism in a multi-receptor agonist is the possibility that you could alter hepatic liver metabolism and potentially decrease fatty acid accumulation and hypertriglyceridemia.
Compounded medications may offer a temporary solution, but a long-term fix will likely require significant policy changes
GLP-1 supplement patches are becoming increasingly popular for individuals looking to enhance their health and wellness
10.1111/bcpt.12974 188